HALIFAX, Dec. 10, 2018 /CNW/ - Adaptiiv Medical Technologies Inc. (Adaptiiv), an innovative medical technology company, announced today the release of its most significant advancement to date of its medical software, 3D Bolus 2.0. This release includes numerous updates to existing features based on client feedback, as well as new features such as;
Hot Spot Correction - Improved hotspot correction algorithm allowing for automatic reduction of hotspots (contoured in the TPS) by a user-selected amount.
Cleaving - Custom cleaving feature provides ability to easily cleave a bolus or applicator into two parts, at any angle.
HDR Surface Brachytherapy - Enhanced algorithm that improves the way catheter trajectories are generated. In addition, the module now notifies Users of curvatures that may be of concern and provides the ability to fix these potential problem areas.
In Vivo Dosimetry - Automatically create and print dosimeter pockets directly within the Bolus/Applicator. Appropriate caps which will fill the pockets when dosimeters are not in use, are also printed.
"This is an exciting time for our organization," said Adaptiiv CTO, Alex Dunphy. "Adaptiiv is the first company in the world to receive FDA 510k clearance for 3D printing software used in radiation oncology. Version 2.0 of the 3D Bolus Software was built by gathering and analyzing feedback from our customers in order to develop a product that meets day-to-day clinical needs. 3D Bolus 2.0 enables our customers to improve the standard of care they provide to the patients, through the 3D printing of patient-specific accessories."
About Adaptiiv Adaptiiv Medical Technologies Inc. (formerly 3D Bolus Inc.) is the definitive 3D technology platform for radiation oncology. Headquartered in Halifax, Nova Scotia, Canada, Adaptiiv is shaping the future of patient-specific healthcare through innovation and collaboration with leading Cancer Centres throughout the world. Adaptiiv has 510(k) clearance, is ISO 13485 certified and has received CE Mark.